1-5 of 5
Olivier Tournilhac
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5' RACE

Vincent Camus, Mathieu Viennot, Pierre-Julien Viailly, Fanny Drieux, Elena-Liana Veresezan, Victor Bobée, Vinciane Rainville, Elodie Bohers, Pierre Sesques, Corinne Haioun, Eric Durot, Michael Bayaram, Cédric Rossi, Laurent Martin, Dominique Penther, Sophie Kaltenbach, Julie Bruneau, Jérôme Paillassa, Olivier Tournilhac, Nicolas Gower, Alexandre Willaume, Chloe Antier, Loïc Renaud, Emilie Leveque, Pierre Decazes, Stéphanie Becker, David Tonnelet, Philippe GAULARD, Hervé Tilly, Thierry Molina, Alexandra Traverse-Glehen, Marie Donzel, Philippe Ruminy, Fabrice Jardin
Journal: Blood Advances
Blood Adv bloodadvances.2024013723.
https://doi.org/10.1182/bloodadvances.2024013723
Published: 2024
Includes: Supplemental data
Journal Articles

High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma

Vincent Camus, Pierre-Julien Viailly, Fanny Drieux, Elena-Liana Veresezan, Pierre Sesques, Corinne Haioun, Eric Durot, Martine Patey, Cédric Rossi, Laurent Martin, Vinciane Rainville, Elodie Bohers, Philippe Ruminy, Dominique Penther, Sophie Kaltenbach, Julie Bruneau, Jérome Paillassa, Olivier Tournilhac, Alexandre Willaume, Chloé Antier, Julien Lazarovici, Emilie Lévêque, Pierre Decazes, Stéphanie Becker, David Tonnelet, Alina Berriolo-Riedinger, Philippe Gaulard, Hervé Tilly, Thierry Jo Molina, Alexandra Traverse-Glehen, Fabrice Jardin
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7331–7345.
https://doi.org/10.1182/bloodadvances.2023011169
Published: 2023
Includes: Supplemental data
Journal Articles

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group

Clinical Trials & Observations
Raphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, Charles Herbaux, Anne Banos, Pauline Brice, David Sibon, Jean Marc Schiano, Thomas Cluzeau, Kamel Laribi, Ronan Le Calloch, Mathieu Bellal, Baptiste Delapierre, Nicolas Daguindau, Sandy Amorim, Kossi Agbetiafa, Adrien Chauchet, Caroline Besson, Eric Durot, Christophe Bonnet, Ludovic Fouillet, Fontanet Bijou, Olivier Tournilhac, Philippe Gaulard, Marie-Cécile Parrens, Gandhi Damaj
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5733–5742.
https://doi.org/10.1182/bloodadvances.2022008524
Published: 2023
Includes: Supplemental data
Journal Articles

A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial

Clinical Trials & Observations
Anne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier, Lydia Campos, Michel Ticchioni, Marie-Sarah Dilhuydy, Stephane Morisset, Valérie Rouille, Béatrice Mahé, Kamel Laribi, Bruno Villemagne, Emmanuelle Ferrant, Olivier Tournilhac, Alain Delmer, Lysiane Molina, Véronique Leblond, Cécile Tomowiak, Sophie de Guibert, Frederique Orsini-Piocelle, Anne Banos, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, Loic Ysebaert, Caroline Dartigeas, Margot Truchan-Graczyk, Jean-Pierre Vilque, Thérèse Aurran Schleinitz, Florence Cymbalista, Stéphane Leprêtre, Vincent Lévy, Florence Nguyen-Khac, Pierre Feugier
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3936–3945.
https://doi.org/10.1182/bloodadvances.2022009594
Published: 2023
Includes: Supplemental data
Journal Articles

Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia

Clinical Trials & Observations
Cécile Tomowiak, Stéphanie Poulain, Charles Herbaux, Aurore Perrot, Béatrice Mahé, Pierre Morel, Thérèse Aurran, Olivier Tournilhac, Stéphane Leprêtre, Souad Assaad, Bruno Villemagne, Olivier Casasnovas, Delphine Nollet, Damien Roos-Weil, Sylvie Chevret, Véronique Leblond
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2438–2446.
https://doi.org/10.1182/bloodadvances.2020003895
Published: 2021
Includes: Supplemental data